Iterum Therapeutics plc CEO Corey Fishman's 2018 pay jumps 133% to $1.8M
Iterum Therapeutics plc reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Iterum Therapeutics plc reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Iterum Therapeutics plc received on average a compensation package of $1.2M, a 110% increase compared to previous year.
Average pay of disclosed executives at Iterum Therapeutics plc
Corey N. Fishman, Chief Executive Officer, received $1.8M in total, which increased by 133% compared to 2017. 54% of Fishman's compensation, or $954K, was in option awards. Fishman also received $306K in non-equity incentive plan, $495K in salary, as well as $2.6K in other compensation.
Michael W. Dunne, Chief Scientific Officer, received a compensation package of $1.1M, which increased by 90% compared to previous year. 52% of the compensation package, or $596K, was in option awards.
Judith M. Matthews, Chief Financial Officer, earned $612K in 2018, a 92% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.